XML 68 R54.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Consolidating Financial Statements Cash Flow (Details) - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Operating Activities:    
Net cash provided by (used in) operating activities $ 42,144 $ (557)
Investing activities:    
Capital expenditures (15,011) (14,120)
Proceeds from sale of assets 0 898
Acquisitions, net of cash received 0 (2,892)
Net cash provided by (used in) investing activities (15,011) (16,114)
Financing activities:    
Proceeds from revolving line of credit 0 10,000
Payments of revolving line of credit 0 (5,500)
Payments on long-term obligations (2,428) (481)
Proceeds from exercise of stock options 69  
Purchase of treasury stock (1,052) (691)
Net cash provided by (used in) financing activities (3,411) 3,328
Net increase (decrease) in cash and cash equivalents 23,722 (13,343)
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]    
Effect of foreign currency fluctuations on cash (1,370) 139
Cash and cash equivalents at beginning of fiscal period 65,004 56,362
Cash and cash equivalents at end of fiscal period 87,356 43,158
Reclassifications and Eliminations    
Operating Activities:    
Net cash provided by (used in) operating activities 0 0
Investing activities:    
Capital expenditures 0 0
Proceeds from sale of assets   0
Acquisitions, net of cash received   0
Net cash provided by (used in) investing activities 0 0
Financing activities:    
Proceeds from revolving line of credit   0
Payments of revolving line of credit   0
Payments on long-term obligations 0 0
Proceeds from exercise of stock options 0  
Purchase of treasury stock 0 0
Net cash provided by (used in) financing activities 0 0
Net increase (decrease) in cash and cash equivalents 0 0
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]    
Effect of foreign currency fluctuations on cash 0 0
Cash and cash equivalents at beginning of fiscal period 0 0
Cash and cash equivalents at end of fiscal period 0 0
Parent    
Operating Activities:    
Net cash provided by (used in) operating activities 2,942 691
Investing activities:    
Capital expenditures 0 0
Proceeds from sale of assets   0
Acquisitions, net of cash received   0
Net cash provided by (used in) investing activities 0 0
Financing activities:    
Proceeds from revolving line of credit   0
Payments of revolving line of credit   0
Payments on long-term obligations (1,870) 0
Proceeds from exercise of stock options 69  
Purchase of treasury stock (1,052) (691)
Net cash provided by (used in) financing activities (2,853) (691)
Net increase (decrease) in cash and cash equivalents 89 0
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]    
Effect of foreign currency fluctuations on cash 0 0
Cash and cash equivalents at beginning of fiscal period 640 640
Cash and cash equivalents at end of fiscal period 729 640
Guarantor Subsidiaries    
Operating Activities:    
Net cash provided by (used in) operating activities 14,962 (8,085)
Investing activities:    
Capital expenditures (5,133) (6,221)
Proceeds from sale of assets   247
Acquisitions, net of cash received   (2,892)
Net cash provided by (used in) investing activities (5,133) (8,866)
Financing activities:    
Proceeds from revolving line of credit   8,000
Payments of revolving line of credit   (5,500)
Payments on long-term obligations 0 0
Proceeds from exercise of stock options 0  
Purchase of treasury stock 0 0
Net cash provided by (used in) financing activities 0 2,500
Net increase (decrease) in cash and cash equivalents 9,829 (14,451)
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]    
Effect of foreign currency fluctuations on cash 0 0
Cash and cash equivalents at beginning of fiscal period 36,209 33,094
Cash and cash equivalents at end of fiscal period 46,038 18,643
Non-Guarantor Subsidiaries    
Operating Activities:    
Net cash provided by (used in) operating activities 24,240 6,837
Investing activities:    
Capital expenditures (9,878) (7,899)
Proceeds from sale of assets   651
Acquisitions, net of cash received   0
Net cash provided by (used in) investing activities (9,878) (7,248)
Financing activities:    
Proceeds from revolving line of credit   2,000
Payments of revolving line of credit   0
Payments on long-term obligations (558) (481)
Proceeds from exercise of stock options 0  
Purchase of treasury stock 0 0
Net cash provided by (used in) financing activities (558) 1,519
Net increase (decrease) in cash and cash equivalents 13,804 1,108
Effect of Exchange Rate on Cash and Cash Equivalents [Abstract]    
Effect of foreign currency fluctuations on cash (1,370) 139
Cash and cash equivalents at beginning of fiscal period 28,155 22,628
Cash and cash equivalents at end of fiscal period $ 40,589 $ 23,875